Navigation Links
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Date:2/8/2010

ABBOTT PARK, Ill., Feb. 8 /PRNewswire-FirstCall/ -- A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States.  Abbott's ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or progression of epithelial ovarian cancer.  If approved, this important immunoassay would be the first automated HE4 test available in the United States.  

The 2003 Hellstrom et al. study of known ovarian cancer biomarkers found that HE4, which has been detected in high levels in the blood of some ovarian cancer patients, shows the highest sensitivity and specificity of any other marker and is considered the best single marker for stage 1 of the disease.  

According to the American Cancer Society, the five-year survival rate of ovarian cancer patients is 46 percent.  However, when the disease is diagnosed and treated earlier, the survival rate increases to 93 percent.  Less than 20 percent of all ovarian cancer is found in the early stage.

"The ability to monitor the recurrence or progression of ovarian cancer is a critical part of patient care.  The ARCHITECT HE4 assay has the potential to be a powerful tool for both physicians and patients in the management of the disease," said Michael Warmuth, senior vice president, diagnostics, Abbott.

Abbott partnered with Fujirebio Diagnostics, Inc. in the development of the assay. The ARCHITECT HE4 assay is approved for use in Europe, as well as in other countries in Asia Pacific and Latin America. It is currently an investigational device in the Uni
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer
2. Abbotts Ibis Technology Named One of the Top Innovations for 2009 by The Scientist
3. The Deal Names Abbott Top Dealmaker for Second Consecutive Year
4. Abbott Completes Visiogen Acquisition
5. Abbott Cuts Use of Oil and Coal by 35 Percent
6. Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
7. Abbotts XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial
8. Abbotts XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
9. Abbotts XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial
10. HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
11. New Data for Abbotts TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Vermillion, Inc. (NASDAQ: VRML), a multivariate ... hold a conference call on Thursday, August 14, 2014, at ... quarter ended June 30, 2014. Financial results will be issued ... Vermillion,s Chairman, President and CEO James LaFrance will ... Date: Thursday, August 14, 2014 Time: 4:30 p.m. ...
(Date:7/31/2014)... 31, 2014 The Galien Foundation today announced ... USA Awards. The Prix Galien ... recognizes the technical, scientific and clinical research skills necessary ... year brings the highest number of nominees since the ... . Nominees include biomedical products across three categories – ...
(Date:7/31/2014)... , July 31, 2014  Genomic Health, Inc. (Nasdaq: ... host a conference call and webcast on Thursday, August 7 ... 2014 financial results.  The call and webcast will follow the ... Conference Call Details To access the live conference ... phone, please dial (877) 303-7208 from the United ...
Breaking Medicine Technology:Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4
(Date:7/31/2014)... Women over the age of 65 face numerous ... greater struggles against poverty and higher rates of asthma ... August issue of Annals of Allergy, Asthma and ... of Allergy, Asthma and Immunology (ACAAI), outlines the challenges ... practical solutions to improve their care. , ...
(Date:7/31/2014)... August 01, 2014 The 2013 ... increasing 0.89 points from 75.07 in 2012. The ... tourism-related sectors and integrates them into an overall ... become increasingly more satisfied with Hong Kong over ... consistently excelling in service performance in Hong Kong ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are now ... a Systematic Review of Sexual Satisfaction . ... International Journal of Clinical and Health Psychology. , This ... need to have accurate information about sexual satisfaction so ... The material provides a systematic review of 197 ...
(Date:7/31/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:7/31/2014)... Vegas, NV (PRWEB) July 31, 2014 Weblify ... Mataka, after 4 years of development and testing. The ... perfectly monetized websites in as little as 5 minutes without ... full Weblify review , Shane Michaels, an SEO expert, ... very quickly. “I’ve seen a lot of web site ...
Breaking Medicine News(10 mins):Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3
... In a major victory for California,s 250,000 In-Home ... people with disabilities who rely on IHSS for daily ... to the IHSS program violate the terms of the ... ruling came after the Service Employees International Union (SEIU) ...
... helps Michigan ,s economy DETROIT, ... Shield of Michigan is striving to further develop its ... to working to address the economic and health security ... Daniel J. Loepp said Thursday.As the keynote speaker on ...
... In his Fiscal Year 2010 (FY 10) budget request, President ... care by $107 million. In doing so, President Obama ... FY 10 budget outline of increasing "resources to detect, prevent, ... is good news for the U.S., especially for people living ...
... IRIDEX Corporation (Nasdaq: IRIX ) today announced that it ... closes on Thursday, May 14, 2009. ... call with the investment community at 5:00 p.m. Eastern ... to discuss the results of the quarter and other business ...
... 7 /PRNewswire/ -- John Fraser, a ... for the Hershey kisses that he and his United States ... "Battle of the Bulge."In a recent letter to the Hershey ... flew 35 missions over enemy territory. I got hit ...
... guidelines to help determine which patients need more ... While some heart patients can safely go home ... coronary intervention, or PCI), others may have to ... says an expert consensus statement released Thursday. , ...
Cached Medicine News:Health News:Obama Administration Rules Against California's Proposed Wage Cuts to Homecare Workers 2Health News:Michigan Blues' CEO Daniel J. Loepp Reinforces Company's Commitment to Minority Business Partners 2Health News:AIDS Action Welcomes President's Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding 2Health News:AIDS Action Welcomes President's Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding 3Health News:World War II Air Force Veteran Remembers 'Kisses' Sweeter Than Wine 2Health News:Discharge Time After Angioplasty Varies 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: